Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Barohn

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
JAMA Neurology|September 19, 2022
Rituximab in Newly Diagnosed Generalized Myasthenia Gravis: A New Treatment Paradigm?Miguel Chuquilin, Richard Barohn
Human Genetics|October 11, 2008
Gene symbol: DMD. Disease: Muscular dystrophy, DuchenneMajed Dasouki, Richard Barohn
Human Genetics|November 10, 2009
Novel human pathological mutations. Gene symbol: DMD. Disease: Muscular Dystrophy, DuchenneMajed Dasouki, Richard Barohn, Hui Zhu
Human Genetics|January 29, 2010
Novel human pathological mutations. Gene symbol: DMD. Disease: Muscular Dystrophy, DuchenneMajed Dasouki, Richard Barohn, Madhuri Hegde
Statistics in Biopharmaceutical Research|December 17, 2019
Using Adaptive Designs to Avoid Selecting the Wrong Arms in Multiarm Comparative Effectiveness TrialsByron J Gajewski, Jeffrey Statland, Richard Barohn
Neurology|March 28, 2020
Practice advisory: Thymectomy for myasthenia gravis (practice parameter update): Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyGary S Gronseth, Richard Barohn, Pushpa Narayanaswami
Journal of Speech, Language, and Hearing Research : JSLHR|September 13, 2018
A Phonetic Complexity-Based Approach for Intelligibility and Articulatory Precision Testing: A Preliminary Study on Talkers With Amyotrophic Lateral SclerosisMili Kuruvilla-Dugdale, Claire Custer, Lindsey Heidrick, et al.
Annals of the New York Academy of Sciences|October 25, 2017
Learning from the past: reflections on recently completed myasthenia gravis trialsMichael Benatar, James F Howard, Richard Barohn, et al.
Journal of Biopharmaceutical Statistics|March 13, 2025
Recurrent neural networks and attention scores for personalized prediction and interpretation of patient-reported outcomesJinxiang Hu, Mohsen Nayebi Kerdabadi, Xiaohang Mei, et al.
Statistics in Medicine|February 3, 2015
Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spotByron J Gajewski, Scott M Berry, Melanie Quintana, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
JAMA Neurology|September 19, 2022
Rituximab in Newly Diagnosed Generalized Myasthenia Gravis: A New Treatment Paradigm?Miguel Chuquilin, Richard Barohn
Human Genetics|October 11, 2008
Gene symbol: DMD. Disease: Muscular dystrophy, DuchenneMajed Dasouki, Richard Barohn
Human Genetics|November 10, 2009
Novel human pathological mutations. Gene symbol: DMD. Disease: Muscular Dystrophy, DuchenneMajed Dasouki, Richard Barohn, Hui Zhu
Human Genetics|January 29, 2010
Novel human pathological mutations. Gene symbol: DMD. Disease: Muscular Dystrophy, DuchenneMajed Dasouki, Richard Barohn, Madhuri Hegde
Statistics in Biopharmaceutical Research|December 17, 2019
Using Adaptive Designs to Avoid Selecting the Wrong Arms in Multiarm Comparative Effectiveness TrialsByron J Gajewski, Jeffrey Statland, Richard Barohn
Neurology|March 28, 2020
Practice advisory: Thymectomy for myasthenia gravis (practice parameter update): Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyGary S Gronseth, Richard Barohn, Pushpa Narayanaswami
Journal of Speech, Language, and Hearing Research : JSLHR|September 13, 2018
A Phonetic Complexity-Based Approach for Intelligibility and Articulatory Precision Testing: A Preliminary Study on Talkers With Amyotrophic Lateral SclerosisMili Kuruvilla-Dugdale, Claire Custer, Lindsey Heidrick, et al.
Annals of the New York Academy of Sciences|October 25, 2017
Learning from the past: reflections on recently completed myasthenia gravis trialsMichael Benatar, James F Howard, Richard Barohn, et al.
Journal of Biopharmaceutical Statistics|March 13, 2025
Recurrent neural networks and attention scores for personalized prediction and interpretation of patient-reported outcomesJinxiang Hu, Mohsen Nayebi Kerdabadi, Xiaohang Mei, et al.
Statistics in Medicine|February 3, 2015
Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spotByron J Gajewski, Scott M Berry, Melanie Quintana, et al.
Pageof 4